Dear Colleague

Over the last decades there has been reports on the use of cannabinoids to treat children with epilepsy. Different cannabinoid formulations has been used that contains different amounts of tetrahydrocannabinol (THC) and cannabidiol (CBD).

We are conducting this international online survey among neuropaediatricians in Norway, Sweden, Denmark, Germany and UK. The purpose is to investigate caretakers knowledge, attitudes and experiences (or lack of) with cannabinoids for treatment of epilepsy in children and adolescents (< 18 years of age).

We greatly appreciate your participation in this short online survey, which we expect to take no more than 5 minutes to complete. Replies will be treated in confidence and results made public in summarized form only.


Thank you in advance 

George Mosulet, Bjørn Bjurulf, Thorsten Gerstner, Helle Hjalgrim and Claus Klingenberg,

Tromsø, Norway
Gothenburg, Sweden
Copenhagen, Denmark
Arendal, Norway